An exit from the recently observed accumulation phase to the upside could allow for the assumption that a clear upward trend is re-established with an increase in volatility. Investors have an opportunity to buy the stock and target the € 65.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.
Viscofan. S.A. accounts for 4.66 % of our European Portfolio. A trade is currently open since 04/22/2020 with a purchase price of € 54.35. Discover the other 19 stocks of the European portfolio managed by the MarketScreener portfolio management team.
The company is in a robust financial situation considering its net cash and margin position.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
The group usually releases upbeat results with huge surprise rates.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Within the weekly time frame the stock shows a bullish technical configuration above the support level at 49.32 EUR
Stock prices approach a strong long-term resistance in weekly data at EUR 60.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.